In a heterozygotic individual, what genetic expression can be expected?
a. Carries normal alleles and displays a normal phenotype
b. Carries one mutant allele and may exhibit an affected phenotype
c. Carries two mutant alleles and has no clinical manifestations
d. Carries normal alleles and exhibits mild clinical manifestations
B
In a heterozygotic individual, one mutant allele and may exhibit an affected phenotype. The homozygotic person with no mutations carries normal alleles and displays a normal phenotype.
You might also like to view...
The physician has ordered the postoperative four-year-old child to receive hydromorphine (Dilaudid) intravenously. The drug book lists a therapeutic range for Dilaudid to be 0.01 to 0.015 mg/kg/dose every three to four hours
What would be the maximum therapeutic dose of Dilaudid if the child weighs 30 pounds? Round your answer to the nearest hundredth. Standard Text:
The nurse is teaching a mother of a young child with a newly diagnosed seizure disorder. The child has been put on valproic acid (Depakote) for control of seizures
The nurse knows that the mother does not understand the effects of valproic acid when she states: 1. "I will not use carbonated beverages to dilute his medication." 2. "I will give his medicine on an empty stomach so he will absorb it better." 3. "I will not let him chew his tablet." 4. "I will bring him to the physician office for regular blood work to check bleeding times."
How might the nurse make use of the information contained in a client's multiaxial diagnosis? Standard Text: Select all that apply
1. To address physiological problems 2. To plan client-centered interventions 3. To communicate client needs 4. To assess client strengths 5. To identify nursing diagnoses
Which reference citation indicates a secondary source?
1. Short, S., Hall, C., Engel, S., & Nigel, C. (2004). Exercise imagery and the stages of change. Journal of Mental Imagery, 28(1,2), 61–78. 2. Jansen, C. E., Miaskowski, C., Dodd, J. S., & Dowling, G. (2005). Chemotherapy-induced cognitive impairment in women with breast cancer: A critique of the literature. Oncology Nursing Forum, 32(2), 329–342. 3. Miaskowski, C. J. (2000). Improving pain management: An ongoing journey. Oncology Nursing Forum, 27(6), 938–944. 4. Loegering, L., Reiter, R., & Gambone, J. (1994). Measuring the quality of health care. Clinical Obstetrics & Gynecology, 37(1), 122–136.